Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 98

Similar articles for PubMed (Select 15178757)

1.

A cardiac arrhythmia syndrome caused by loss of ankyrin-B function.

Mohler PJ, Splawski I, Napolitano C, Bottelli G, Sharpe L, Timothy K, Priori SG, Keating MT, Bennett V.

Proc Natl Acad Sci U S A. 2004 Jun 15;101(24):9137-42. Epub 2004 Jun 3.

2.

Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death.

Mohler PJ, Schott JJ, Gramolini AO, Dilly KW, Guatimosim S, duBell WH, Song LS, Haurogné K, Kyndt F, Ali ME, Rogers TB, Lederer WJ, Escande D, Le Marec H, Bennett V.

Nature. 2003 Feb 6;421(6923):634-9.

PMID:
12571597
3.

Defining new insight into atypical arrhythmia: a computational model of ankyrin-B syndrome.

Wolf RM, Mitchell CC, Christensen MD, Mohler PJ, Hund TJ.

Am J Physiol Heart Circ Physiol. 2010 Nov;299(5):H1505-14. doi: 10.1152/ajpheart.00503.2010. Epub 2010 Aug 20.

4.

Ankyrin-B coordinates the Na/K ATPase, Na/Ca exchanger, and InsP3 receptor in a cardiac T-tubule/SR microdomain.

Mohler PJ, Davis JQ, Bennett V.

PLoS Biol. 2005 Dec;3(12):e423. Epub 2005 Nov 29.

5.

Ankyrin-based cardiac arrhythmias: a new class of channelopathies due to loss of cellular targeting.

Mohler PJ, Bennett V.

Curr Opin Cardiol. 2005 May;20(3):189-93. Review.

PMID:
15861006
6.

Ankyrin-based targeting pathway regulates human sinoatrial node automaticity.

Hund TJ, Mohler PJ.

Channels (Austin). 2008 Nov-Dec;2(6):404-6. Epub 2008 Nov 20.

7.

Defining the cellular phenotype of "ankyrin-B syndrome" variants: human ANK2 variants associated with clinical phenotypes display a spectrum of activities in cardiomyocytes.

Mohler PJ, Le Scouarnec S, Denjoy I, Lowe JS, Guicheney P, Caron L, Driskell IM, Schott JJ, Norris K, Leenhardt A, Kim RB, Escande D, Roden DM.

Circulation. 2007 Jan 30;115(4):432-41. Epub 2007 Jan 22.

8.

Ankyrin-B is required for coordinated expression of beta-2-spectrin, the Na/K-ATPase and the Na/Ca exchanger in the inner segment of rod photoreceptors.

Kizhatil K, Sandhu NK, Peachey NS, Bennett V.

Exp Eye Res. 2009 Jan;88(1):57-64. doi: 10.1016/j.exer.2008.09.022. Epub 2008 Nov 1.

PMID:
19007774
9.

Atrial fibrillation and sinus node dysfunction in human ankyrin-B syndrome: a computational analysis.

Wolf RM, Glynn P, Hashemi S, Zarei K, Mitchell CC, Anderson ME, Mohler PJ, Hund TJ.

Am J Physiol Heart Circ Physiol. 2013 May;304(9):H1253-66. doi: 10.1152/ajpheart.00734.2012. Epub 2013 Feb 22.

10.

Ankyrin-B reduction enhances Ca spark-mediated SR Ca release promoting cardiac myocyte arrhythmic activity.

Camors E, Mohler PJ, Bers DM, Despa S.

J Mol Cell Cardiol. 2012 Jun;52(6):1240-8. doi: 10.1016/j.yjmcc.2012.02.010. Epub 2012 Mar 3.

11.

Targeting and stability of Na/Ca exchanger 1 in cardiomyocytes requires direct interaction with the membrane adaptor ankyrin-B.

Cunha SR, Bhasin N, Mohler PJ.

J Biol Chem. 2007 Feb 16;282(7):4875-83. Epub 2006 Dec 18.

12.

Abnormal cardiac Na(+) channel properties and QT heart rate adaptation in neonatal ankyrin(B) knockout mice.

Chauhan VS, Tuvia S, Buhusi M, Bennett V, Grant AO.

Circ Res. 2000 Mar 3;86(4):441-7.

13.

Defects in ankyrin-based membrane protein targeting pathways underlie atrial fibrillation.

Cunha SR, Hund TJ, Hashemi S, Voigt N, Li N, Wright P, Koval O, Li J, Gudmundsson H, Gumina RJ, Karck M, Schott JJ, Probst V, Le Marec H, Anderson ME, Dobrev D, Wehrens XH, Mohler PJ.

Circulation. 2011 Sep 13;124(11):1212-22. doi: 10.1161/CIRCULATIONAHA.111.023986. Epub 2011 Aug 22.

14.

Human genetics: Lost anchors cost lives.

Nattel S.

Nature. 2003 Feb 6;421(6923):587, 589-90. No abstract available.

PMID:
12571577
15.

Inositol 1,4,5-trisphosphate receptor localization and stability in neonatal cardiomyocytes requires interaction with ankyrin-B.

Mohler PJ, Davis JQ, Davis LH, Hoffman JA, Michaely P, Bennett V.

J Biol Chem. 2004 Mar 26;279(13):12980-7. Epub 2004 Jan 13.

16.

Dysfunction in the βII spectrin-dependent cytoskeleton underlies human arrhythmia.

Smith SA, Sturm AC, Curran J, Kline CF, Little SC, Bonilla IM, Long VP, Makara M, Polina I, Hughes LD, Webb TR, Wei Z, Wright P, Voigt N, Bhakta D, Spoonamore KG, Zhang C, Weiss R, Binkley PF, Janssen PM, Kilic A, Higgins RS, Sun M, Ma J, Dobrev D, Zhang M, Carnes CA, Vatta M, Rasband MN, Hund TJ, Mohler PJ.

Circulation. 2015 Feb 24;131(8):695-708. doi: 10.1161/CIRCULATIONAHA.114.013708. Epub 2015 Jan 28.

PMID:
25632041
17.

Cardiac ankyrins: Essential components for development and maintenance of excitable membrane domains in heart.

Cunha SR, Mohler PJ.

Cardiovasc Res. 2006 Jul 1;71(1):22-9. Epub 2006 Mar 28. Review.

18.

Cardiac ankyrins in health and disease.

Hashemi SM, Hund TJ, Mohler PJ.

J Mol Cell Cardiol. 2009 Aug;47(2):203-9. doi: 10.1016/j.yjmcc.2009.04.010. Epub 2009 Apr 24. Review.

19.

CaMKII inhibition rescues proarrhythmic phenotypes in the model of human ankyrin-B syndrome.

DeGrande S, Nixon D, Koval O, Curran JW, Wright P, Wang Q, Kashef F, Chiang D, Li N, Wehrens XH, Anderson ME, Hund TJ, Mohler PJ.

Heart Rhythm. 2012 Dec;9(12):2034-41. doi: 10.1016/j.hrthm.2012.08.026. Epub 2012 Aug 28.

20.

Molecular basis for PP2A regulatory subunit B56alpha targeting in cardiomyocytes.

Bhasin N, Cunha SR, Mudannayake M, Gigena MS, Rogers TB, Mohler PJ.

Am J Physiol Heart Circ Physiol. 2007 Jul;293(1):H109-19. Epub 2007 Apr 6.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk